Live feed16:35:50·589dINSIDERFilingvia QuantisnowHead of R&D Lenz Robert A. sold $492,827 worth of shares (41,464 units at $11.89), decreasing direct ownership by 11% to 328,529 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.NMRA· Neumora Therapeutics Inc.Health CareOriginal source